95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-21.32%
Operating expenses reduction while OR shows 24.52% growth. Joel Greenblatt would examine advantage.
-21.32%
Total costs reduction while OR shows 15.46% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.32%
EBITDA growth exceeding 1.5x OR's 12.05%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
21.32%
Operating income growth exceeding 1.5x OR's 7.56%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
15159.69%
Tax expense growth while OR reduces burden. John Neff would investigate differences.
-498.04%
Net income decline while OR shows 26.20% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
-498.20%
EPS decline while OR shows 21.43% growth. Joel Greenblatt would examine position.
-498.20%
Diluted EPS decline while OR shows 21.43% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.